The maker of Excedrin is temporarily discontinuing two of the brand’s most popular headache-relief medicines, potentially affecting millions of Americans who suffer from migraines. GlaxoSmithKline is ...

Novartis (NVS) should discontinue ads that say its Extra Strength Excedrin starts to relieve headaches in 15 minutes, according to the National Advertising Review Board, an appeals body that governs ...

Thanksgiving is next week, which means the holiday season — and its associated stress — is about to kick into high gear. Given that this is typically a stressful time of year for most Americans, ...

There's a nationwide shortage of Excedrin, a popular pain relief medication. The drugmaker, GlaxoSmithKline, has temporarily halted production to work out issues with the transfer and weighing of ...

GlaxoSmithKline is temporarily halting nationwide production of some of its Excedrin products, ABC affiliate WSYR reported. The drugmaker is halting production of Excedrin Extra Strength and Excedrin ...